Types of Clinical Trials
MYTH – Clinical trials always involve dead risk.
FACT – Not always.
Clinical Trial
To try new interventions or drugs to prevent, detect or treat a disease.
Clinical Study
Any study involving a person whether or not to test a specific intervention.
Prevention Trial
Doctors look for ways to stop the development of Alzheimer’s in people who are in high risk of developing it.
Quality of Life Studies
To understand the needs of Alzheimer’s patients, their families and caregivers.
Diagnostic Studies
Search for the best ways to correctly diagnose the disease before symptoms appear.
Online Studies
Studies that explore and extract information from online questionnaires.
Myths Vs. Facts
MYTH: It’s untested treatments
FACT: A clinical trial is the first attempt to test in humans de medicine or treatment, but it’s already tested on animals and approved by the IRB -Institutional Review Board- and the EC – Ethics Committee-. IRB and EC are responsible of protecting the well being and rights of clinical trial participants
MYTH: Once I made my decision I can’t back out
FACT: You have the right to back out without explanation, as well, the professionals in charge have the right to withdraw any participant at any time for their safety or well-being.
MYTH: I don’t have any say in the decision of the people in charge of the trial.
FACT: You are a key part of the trial and everything you are feeling is important to complete the research. You must follow the instructions of the study team, but you can ask all your questions and express your feelings honestly, as well as attend your scheduled visits and know the evolution of your disease.
Different Stages in a Clinical Trial
Phase I
Investigate the safety of the drug, determine frequent and serious effects, how it is metabolized and excreted from the body, in healthy people.ch our growing community.
Phase II
Preliminary data on how it works in sick patients, compare results with other drugs or placebos.
Phase III
To determine the safety and efficacy in different populations, doses and combinations of drugs.
Phase IV
Follow-up clinical research after the drug is approved by the FDA, checking for long-term adverse effects, safety, efficacy, and optimal use.